Peter D. Kies
2012
In 2012, Peter D. Kies earned a total compensation of $461.2K as Chief Financial Officer at Inovio Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $69,600 |
|---|---|
| Option Awards | $84,749 |
| Salary | $301,545 |
| Other | $5,354 |
| Total | $461,248 |
Kies received $301.5K in salary, accounting for 65% of the total pay in 2012.
Kies also received $69.6K in bonus, $84.7K in option awards and $5.4K in other compensation.
Rankings
In 2012, Peter D. Kies' compensation ranked 8,998th out of 11,487 executives tracked by ExecPay. In other words, Kies earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,998 out of 11,487 | 22nd |
Division Manufacturing | 3,293 out of 4,253 | 23rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 478 out of 624 | 23rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 269 out of 365 | 26th |
Industry Surgical and Medical Instruments and Apparatus | 161 out of 220 | 27th |
Source: SEC filing on March 29, 2013.
Kies' colleagues
We found four more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2012.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019